Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | yes | yes: 20 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 1, no: 18 |
NetGPI | no | yes: 0, no: 19 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005759 | mitochondrial matrix | 5 | 20 |
GO:0031974 | membrane-enclosed lumen | 2 | 20 |
GO:0043233 | organelle lumen | 3 | 20 |
GO:0070013 | intracellular organelle lumen | 4 | 20 |
GO:0110165 | cellular anatomical entity | 1 | 20 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 13 | 17 | PF00656 | 0.460 |
CLV_C14_Caspase3-7 | 74 | 78 | PF00656 | 0.645 |
CLV_NRD_NRD_1 | 11 | 13 | PF00675 | 0.563 |
CLV_NRD_NRD_1 | 24 | 26 | PF00675 | 0.516 |
CLV_NRD_NRD_1 | 49 | 51 | PF00675 | 0.446 |
CLV_PCSK_KEX2_1 | 11 | 13 | PF00082 | 0.562 |
CLV_PCSK_KEX2_1 | 133 | 135 | PF00082 | 0.308 |
CLV_PCSK_KEX2_1 | 160 | 162 | PF00082 | 0.374 |
CLV_PCSK_KEX2_1 | 24 | 26 | PF00082 | 0.512 |
CLV_PCSK_PC1ET2_1 | 133 | 135 | PF00082 | 0.356 |
CLV_PCSK_PC1ET2_1 | 160 | 162 | PF00082 | 0.374 |
DOC_CKS1_1 | 39 | 44 | PF01111 | 0.610 |
DOC_PP2B_LxvP_1 | 7 | 10 | PF13499 | 0.562 |
DOC_USP7_MATH_1 | 10 | 14 | PF00917 | 0.724 |
DOC_WW_Pin1_4 | 38 | 43 | PF00397 | 0.616 |
LIG_14-3-3_CanoR_1 | 11 | 19 | PF00244 | 0.445 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.508 |
LIG_CtBP_PxDLS_1 | 65 | 71 | PF00389 | 0.520 |
LIG_deltaCOP1_diTrp_1 | 184 | 193 | PF00928 | 0.480 |
LIG_FHA_1 | 137 | 143 | PF00498 | 0.549 |
LIG_FHA_1 | 54 | 60 | PF00498 | 0.479 |
LIG_FHA_2 | 124 | 130 | PF00498 | 0.505 |
LIG_FHA_2 | 154 | 160 | PF00498 | 0.470 |
LIG_FHA_2 | 21 | 27 | PF00498 | 0.482 |
LIG_FHA_2 | 72 | 78 | PF00498 | 0.583 |
LIG_GBD_Chelix_1 | 142 | 150 | PF00786 | 0.374 |
LIG_LIR_Apic_2 | 136 | 141 | PF02991 | 0.486 |
LIG_LIR_Gen_1 | 145 | 155 | PF02991 | 0.574 |
LIG_LIR_Gen_1 | 169 | 178 | PF02991 | 0.574 |
LIG_LIR_LC3C_4 | 66 | 70 | PF02991 | 0.518 |
LIG_LIR_Nem_3 | 145 | 151 | PF02991 | 0.513 |
LIG_LIR_Nem_3 | 169 | 173 | PF02991 | 0.555 |
LIG_LRP6_Inhibitor_1 | 109 | 115 | PF00058 | 0.374 |
LIG_PTB_Apo_2 | 110 | 117 | PF02174 | 0.525 |
LIG_SH2_CRK | 138 | 142 | PF00017 | 0.511 |
LIG_SH2_CRK | 148 | 152 | PF00017 | 0.511 |
LIG_SH2_NCK_1 | 117 | 121 | PF00017 | 0.575 |
LIG_SH2_SRC | 117 | 120 | PF00017 | 0.560 |
LIG_SH2_STAP1 | 117 | 121 | PF00017 | 0.610 |
LIG_SH2_STAP1 | 174 | 178 | PF00017 | 0.492 |
LIG_SH2_STAP1 | 183 | 187 | PF00017 | 0.464 |
LIG_SH2_STAT3 | 89 | 92 | PF00017 | 0.574 |
LIG_SH2_STAT5 | 138 | 141 | PF00017 | 0.559 |
LIG_SH2_STAT5 | 157 | 160 | PF00017 | 0.457 |
LIG_SH2_STAT5 | 89 | 92 | PF00017 | 0.530 |
LIG_SH3_3 | 34 | 40 | PF00018 | 0.539 |
LIG_SH3_3 | 46 | 52 | PF00018 | 0.480 |
LIG_TRAF2_1 | 103 | 106 | PF00917 | 0.574 |
LIG_TYR_ITIM | 146 | 151 | PF00017 | 0.551 |
LIG_UBA3_1 | 86 | 93 | PF00899 | 0.485 |
LIG_WRC_WIRS_1 | 173 | 178 | PF05994 | 0.567 |
MOD_CK1_1 | 2 | 8 | PF00069 | 0.735 |
MOD_CK2_1 | 100 | 106 | PF00069 | 0.575 |
MOD_CK2_1 | 123 | 129 | PF00069 | 0.511 |
MOD_CK2_1 | 153 | 159 | PF00069 | 0.536 |
MOD_CK2_1 | 20 | 26 | PF00069 | 0.434 |
MOD_GlcNHglycan | 1 | 4 | PF01048 | 0.654 |
MOD_GlcNHglycan | 12 | 15 | PF01048 | 0.475 |
MOD_GSK3_1 | 53 | 60 | PF00069 | 0.444 |
MOD_GSK3_1 | 71 | 78 | PF00069 | 0.609 |
MOD_NEK2_1 | 57 | 62 | PF00069 | 0.418 |
MOD_PIKK_1 | 88 | 94 | PF00454 | 0.470 |
MOD_PKA_2 | 10 | 16 | PF00069 | 0.650 |
MOD_PKA_2 | 70 | 76 | PF00069 | 0.548 |
MOD_Plk_1 | 100 | 106 | PF00069 | 0.564 |
MOD_Plk_4 | 153 | 159 | PF00069 | 0.494 |
MOD_Plk_4 | 172 | 178 | PF00069 | 0.494 |
MOD_ProDKin_1 | 38 | 44 | PF00069 | 0.620 |
MOD_SUMO_rev_2 | 159 | 167 | PF00179 | 0.574 |
TRG_DiLeu_BaEn_1 | 105 | 110 | PF01217 | 0.536 |
TRG_DiLeu_BaEn_1 | 64 | 69 | PF01217 | 0.539 |
TRG_ENDOCYTIC_2 | 148 | 151 | PF00928 | 0.551 |
TRG_ER_diArg_1 | 10 | 12 | PF00400 | 0.589 |
TRG_Pf-PMV_PEXEL_1 | 25 | 29 | PF00026 | 0.540 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P990 | Leptomonas seymouri | 86% | 84% |
A0A0N1HS24 | Leptomonas seymouri | 24% | 76% |
A0A0S4ITN8 | Bodo saltans | 40% | 86% |
A0A1X0NTH7 | Trypanosomatidae | 25% | 75% |
A0A1X0P207 | Trypanosomatidae | 46% | 87% |
A0A3Q8IBW7 | Leishmania donovani | 98% | 84% |
A0A3Q8IFM4 | Leishmania donovani | 28% | 76% |
A0A422P4Z7 | Trypanosoma rangeli | 40% | 87% |
A4HCI6 | Leishmania braziliensis | 28% | 79% |
A4HI52 | Leishmania braziliensis | 93% | 100% |
A4I007 | Leishmania infantum | 28% | 76% |
A4I5C8 | Leishmania infantum | 98% | 96% |
C9ZQR0 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 37% | 86% |
C9ZSQ9 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 28% | 75% |
E9AVY0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 28% | 78% |
E9B0M6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 97% | 84% |
Q4QBJ9 | Leishmania major | 28% | 78% |
V5BDB3 | Trypanosoma cruzi | 25% | 75% |